Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Julian C Schink
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
289 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Odette Cancer Centre- Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
- Chum - Hopital Notre-Dame
Montreal, Quebec, Canada
- Tohoku University School of Medicine
Sendai, Aoba-ku, Japan
- Kure National Hospital
Kure, Hiroshima, Japan
- Hokkaido University Hospital
Sapporo, Hokkaido, Japan
- Iwate Medical University Hospital
Shiwa-gun, Iwate, Japan
- Kagoshima City Hospital
Kagoshima, Kagoshima-ken, Japan
- Niigata University Medical and Dental Hospital
Niigata, Niigata, Japan
- University of the Ryukyus Hospital-Col Health Scnc
Nakagami-gun, Okinawa, Japan
- Hiroshima University Hospital
Hiroshima, Japan
- Kindai University
Osaka, Japan
- Saitama Medical University International Medical Center
Saitama, Japan
- Tottori University
Tottori, Japan
- Catholic University of Korea-Seoul Saint Mary'S Hospital
Seoul, Korea, South Korea
- Samsung Medical Center
Seoul, Korea, South Korea
- Seoul National University Bundang Hospital
Seongnam, Kyeonggi-do, South Korea
- Gachon University Gil Hospital
Incheon, South Korea
- Asan Medical Center
Seoul, South Korea
- Gangnam Severance Hospital
Seoul, South Korea
- Korea Cancer Center Hospital
Seoul, South Korea
- Seoul National University Hospital
Seoul, South Korea
- Weston Park Hospital
Sheffield, England, United Kingdom
- Alaska Breast Care and Surgery Llc
Anchorage, Alaska, United States
- Alaska Oncology and Hematology Llc
Anchorage, Alaska, United States
- Alaska Regional Hospital
Anchorage, Alaska, United States
- Alaska Women'S Cancer Care
Anchorage, Alaska, United States
- Anchorage Associates in Radiation Medicine
Anchorage, Alaska, United States
- Anchorage Oncology Centre
Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center
Anchorage, Alaska, United States
- Katmai Oncology Group
Anchorage, Alaska, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Cancer Center at Saint Joseph'S
Phoenix, Arizona, United States
- Saint Joseph'S Hospital and Medical Center
Phoenix, Arizona, United States
- Providence Saint Joseph Medical Center/disney Family Cancer Center
Burbank, California, United States
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- Loma Linda University Medical Center
Loma Linda, California, United States
- Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, United States
- Hartford Hospital
Hartford, Connecticut, United States
- the Hospital of Central Connecticut
New Britain, Connecticut, United States
- Northside Hospital
Atlanta, Georgia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 Jun 2012
- Primary completion
- 31 May 2018
- Completion
- 17 Jul 2020
- Last update posted
- 12 Aug 2022
- Registered enrollment
- 57
- Registry id
- NCT01535053
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.